ABI Vascular Diagnostic System

SOT AngE ABI+

AngE ABI+ — automatic ABI, TBI, segmental pressures and PVR, simultaneous four-cuff measurement

SOT AngE ABI+ from SOT Medical Systems is an automatic vascular diagnostic system for simultaneous ABI, TBI, segmental pressure and pulse volume recording measurements for PAD screening and follow-up.

Manufactured bySOT Medical Systems
SOT Medical Systems logo
SOT AngE ABI+ abi vascular diagnostic system
SOT AngE ABI+ from SOT Medical Systems.
4 cuffsSimultaneous measurement
ABI · TBIAutomatic indices
PVRWaveform analysis
SegmentalBlood pressures
CE · ISO 13485Approvals
Overview

Automatic ABI and TBI testing for PAD screening

AngE ABI+ by SOT Medical Systems is a vascular assessment platform for early detection and monitoring of Peripheral Arterial Disease (PAD). It performs fully automatic, simultaneous measurements of Ankle-Brachial Index (ABI), Toe-Brachial Index (TBI), pulse volume recording (PVR), segmental blood pressures and waveform analysis.

The system includes an algorithm for PAD risk classification and produces detailed reports compliant with international vascular guidelines. It combines oscillometric and plethysmographic technologies for measurement even in patients with calcified or non-compressible arteries.

Its compact design and quick measurement cycles suit routine vascular screening in outpatient clinics, endocrinology centers, diabetic foot clinics, hospitals and general practices.

Applications

Where the AngE ABI+ is used

AngE ABI+ is used for PAD screening and vascular risk assessment in primary care and specialty settings.

PAD

PAD Screening

Automatic ABI and TBI measurement for Peripheral Arterial Disease screening.

Diabetic Foot

Diabetic Foot Evaluation

Vascular assessment of diabetic patients, including non-compressible arteries.

Follow-Up

Vascular Follow-Up

Repeat measurements for vascular risk assessment and follow-up monitoring.

Segmental

Segmental Pressures

Segmental blood pressure measurement in primary care and vascular diagnostics.

PAD screeningDiabetic foot evaluationVascular risk assessmentFollow-up monitoringPrimary careVascular diagnostics
Features

Measurements, interpretation and reporting

Measurements

  • Automatic ABI and TBI measurement.
  • Simultaneous four-cuff measurement setup.
  • Pulse Volume Recording (PVR) waveform analysis.
  • Segmental blood pressure measurement.

Technology & Interpretation

  • High-accuracy oscillometric and plethysmographic technology.
  • PAD risk assessment and automated interpretation tools.

Workflow & Design

  • Fast test cycle designed for routine vascular screening.
  • Compact hardware with easy patient setup.

Reporting & Connectivity

  • Integrated report generation with guideline-compliant formats.
  • Connectivity to PC software for data review and archiving.
Benefits

Why it suits routine vascular screening

Rapid Assessment. Provides rapid, reproducible PAD assessment in routine practice.
Shorter Testing. Simultaneous ABI, TBI and PVR measurement reduces measurement time.
Diabetic Patients. Suitable for diabetic patients with non-compressible arteries.
Clear Analysis. Clear waveform and segmental pressure analysis supports diagnostic confidence.
Documentation. Comprehensive reports support clinical documentation and referral.

Need support with this vascular diagnostic system?

Share your clinical department, required measurements (ABI, TBI, PVR or segmental pressures) and expected patient volume, and our medical technologies team will support you with the suitable product information.

Request Information
Medical Technologies Division

Other Products in Non-Invasive Vascular Labs

Explore other products available within the same product category and open each page for complete technical details.

Medical Technologies Division

Request Medical Technologies Information

Share your requirements — our specialists reply within one working day.

Noor Scientific & Trade

Request Information

Share your requirements — our team will route your inquiry to the right division and reply within one working day.